Juan Carlos Plana, MD

Juan Carlos Plana Gomez, M.D, is Chief of Clinical Operations of the Section of Cardiology, Department of Medicine at Baylor College of Medicine, Director of the Cardio-Oncology Center, and co-Director of the Center for Advanced Cardiac Imaging at Baylor St. Luke’s Medical Center. He is the Don W. Chapman Chair in Cardiology and tenured Associate Professor of Medicine. Dr. Plana is board certified in Cardiology and Echocardiography.

Show full bio

Dr. Plana earned his medical degree from Pontificia Universidad Javeriana, Santafé de Bogotá (Colombia). His extensive training included internship, residency, chief resident year and fellowship in Cardiovascular disease and Cardiac Imaging (echocardiography and Nuclear Cardiology) at Baylor College of Medicine.

Dr. Plana’s academic career started at The University of Texas MD Anderson Cancer Center where he served as Director of Cardiac Imaging and Medical Director of the Echocardiography laboratory. In 2010, he was recruited to Cleveland Clinic, where he opened as served as Co-Director of the Cardio-Oncology center.
Dr. Plana’s clinical and research interests include Cardio-Oncology, valvular heart disease, diseases of the aorta, and advanced cardiac imaging.

The major focus of Dr. Plana’s clinical and scholarly interest is the development and application of novel echocardiographic techniques in the early detection of cardiac dysfunction caused by chemotherapeutic agents. His work has led to 38 reports published in the peer-reviewed literature, as well as 8 invited reviews and book chapters. He authored the Expert consensus for multi-modality Imaging evaluation of cardiovascular complications of radiotherapy in adults, and more recently chaired the Expert consensus for the multi-modality Imaging evaluation of adult patients during and after cancer therapy: a joint effort of the American Society of Echocardiography and the European Association of Cardiovascular Imaging. His national and international stature in the field of Cardio-Oncology and cardiac imaging is reflected by his 122 invited presentations at national and international conferences; his invited service to 5 journal editorial boards (including his current service to the International Board of the Journal of Cardiovascular Echocardiography); and his invited service to, and leadership of multiple committees of the American Society of Echocardiography (for which he currently serves on the Board of Directors) and other professional societies (representing the United States on the Echocardiography Section of the Inter-American Society of Cardiology) , as well as to the NIH (NCI/NHLBI) (member of the Expert Panel on Cardio-toxicity) and the FDA.

In addition to his scholarly efforts, Dr. Plana has been a dedicated educator, having received major teaching awards from BCM (Excellence in Teaching Award, 2000), MD Anderson Cancer Center (Teacher of the Year Award, Section of Cardiology, U. Texas Health Science Center, 2007), and the Cleveland Clinic (Teacher of the Year Award, Department of Cardiovascular Medicine, 2011) .

See Publications

Texas Heart Institute Positions

Education

  • Medical School:

    Pontificia Universidad Javeriana

  • Residency:

    Baylor College of Medicine

  • Fellowships:

    Baylor College of Medicine

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center
  • Texas Children's Hospital

Honors, Awards and Memberships

Publications

4862227 M32R8FP2 1 alternatives-to-animal-experimentation 10 date desc Plana 2052 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IUP3W9N4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kamat%20et%20al.%22%2C%22parsedDate%22%3A%222022-05-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKamat%2C%20I.%20S.%2C%20Nazir%2C%20S.%2C%20Minhas%2C%20A.%20M.%20K.%20et%20al.%20%282022%29.%20Outcomes%20of%20hospitalizations%20with%20septic%20shock%20complicated%20by%20types%201%20and%202%20myocardial%20infarction.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%2C%20S0002-9149%2822%2900333%26%23x2013%3B2.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2022.03.027%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2022.03.027%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20of%20hospitalizations%20with%20septic%20shock%20complicated%20by%20types%201%20and%202%20myocardial%20infarction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ishan%20S.%22%2C%22lastName%22%3A%22Kamat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salik%22%2C%22lastName%22%3A%22Nazir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Mannan%20Khan%22%2C%22lastName%22%3A%22Minhas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Nambi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prathit%22%2C%22lastName%22%3A%22Kulkarni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Musher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biykem%22%2C%22lastName%22%3A%22Bozkurt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22Septic%20shock%20is%20a%20life-threatening%20host%20response%20to%20infection%20and%20a%20significant%20contributor%20to%20cost%20burden%20in%20the%20United%20States.%20Furthermore%2C%20sepsis-related%20inflammation%20has%20been%20linked%20to%20myocardial%20infarction%20%28MI%29.%20We%20sought%20to%20examine%20the%20association%20of%20type%201%20and%20type%202%20MI%20with%20outcomes%20in%20hospitalizations%20admitted%20with%20septic%20shock.%20The%20National%20Readmission%20Database%202018%20was%20queried%20to%20identify%20hospitalizations%20with%20hospital%20discharge%20diagnoses%20of%20septic%20shock%20without%20MI%2C%20septic%20shock%20with%20type%201%20MI%2C%20or%20septic%20shock%20with%20type%202%20MI.%20Complex-sample%20multivariable%20logistic%20and%20linear%20regression%20models%20were%20used%20to%20determine%20the%20association%20of%20these%20conditions%20with%20clinical%20outcomes.%20Of%20354%2C528%20hospitalizations%20with%20septic%20shock%2C%2011%2C519%20had%20type%201%20MI%20%283.2%25%29%20and%2013%2C970%20had%20type%202%20MI%20%283.9%25%29.%20Compared%20with%20septic%20shock%20without%20MI%2C%20type%201%20MI%20was%20associated%20with%20higher%20mortality%20%28adjusted%20odds%20ratio%20%5BOR%5D%201.67%2C%2095%25%20confidence%20interval%20%5BCI%5D%201.57%20to%201.77%29%2C%20costs%20%28adjusted%20parameter%20estimate%20%244%2C571%2C%2095%25%20CI%203%2C020%20to%206%2C122%29%2C%20and%20discharge%20to%20facility%20%28adjusted%20OR%201.09%2C%2095%25%20CI%201.01%20to%201.17%29.%20In%20contrast%2C%20septic%20shock%20with%20type%202%20MI%20was%20associated%20with%20similar%20mortality%20and%20discharge%20to%20nursing%20facility%20and%20higher%20costs%20%28adjusted%20parameter%20estimate%201%2C798%2C%2095%25%20CI%20549%20to%203%2C047%29.%20Septic%20shock%20hospitalizations%20with%20type%201%20MI%20had%20higher%20in-hospital%20mortality%20%28adjusted%20OR%201.74%2C%2095%25%20CI%201.60%20to%201.90%2C%20p%20%26lt%3B0.001%29%20compared%20with%20type%202%20MI.%20In%20conclusion%2C%20type%201%20MI%20is%20associated%20with%20higher%20mortality%20and%20resource%20utilization%20among%20septic%20shock%20hospitalizations.%20Furthermore%2C%20type%202%20MI%20was%20associated%20with%20higher%20resource%20utilization.%22%2C%22date%22%3A%22May%2003%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2022.03.027%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%2C%22V4E2TPM3%22%2C%22GL8QP2FN%22%5D%2C%22dateModified%22%3A%222023-01-12T21%3A53%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22NC6CBSRL%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jefferies%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJefferies%2C%20J.%20L.%2C%20Mazur%2C%20W.%20M.%2C%20Howell%2C%20C.%20R.%20et%20al.%20%282021%29.%20Cardiac%20remodeling%20after%20anthracycline%20and%20radiotherapy%20exposure%20in%20adult%20survivors%20of%20childhood%20cancer%3A%20A%20report%20from%20the%20St%20Jude%20Lifetime%20Cohort%20Study.%20%26lt%3Bi%26gt%3BCancer%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B127%26lt%3B%5C%2Fi%26gt%3B%2C%204646%26%23x2013%3B4655.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcncr.33860%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcncr.33860%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20remodeling%20after%20anthracycline%20and%20radiotherapy%20exposure%20in%20adult%20survivors%20of%20childhood%20cancer%3A%20A%20report%20from%20the%20St%20Jude%20Lifetime%20Cohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20L.%22%2C%22lastName%22%3A%22Jefferies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wojciech%20M.%22%2C%22lastName%22%3A%22Mazur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20R.%22%2C%22lastName%22%3A%22Howell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20C.%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirsten%20K.%22%2C%22lastName%22%3A%22Ness%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhenghong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijaya%20M.%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20M.%22%2C%22lastName%22%3A%22Green%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Mulrooney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Towbin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%20R.%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20F.%22%2C%22lastName%22%3A%22Goldberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20M.%22%2C%22lastName%22%3A%22Howell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deo%20Kumar%22%2C%22lastName%22%3A%22Srivastava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20L.%22%2C%22lastName%22%3A%22Robison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20M.%22%2C%22lastName%22%3A%22Hudson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20T.%22%2C%22lastName%22%3A%22Armstrong%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Limited%20data%20exist%20regarding%20left%20ventricular%20remodeling%20patterns%20observed%20in%20adult%20survivors%20of%20childhood%20cancer%20after%20therapy.%5CnMETHODS%3A%20Among%201190%20adult%20survivors%20diagnosed%20with%20childhood%20cancer%20%28median%20age%20at%20diagnosis%2C%209%20years%20%5Binterquartile%20range%20%28IQR%29%2C%203.8-14.4%20years%5D%3B%20age%20at%20evaluation%2C%2035.6%20years%20%5BIQR%2C%2029.5-42.8%20years%5D%29%2C%20treatment%20exposures%20included%20anthracyclines%20%28n%20%3D%20346%29%2C%20chest%20radiotherapy%20%28n%20%3D%20174%29%2C%20both%20%28n%20%3D%20245%29%2C%20or%20neither%20%28n%20%3D%20425%29.%20Prospective%20echocardiographic%20assessment%20compared%20survivors%20with%20449%20noncancer%20controls%20classified%20according%20to%20left%20ventricle%20geometric%20patterns.%20Associations%20between%20left%20ventricle%20geometric%20patterns%20and%20decreased%20exercise%20tolerance%20were%20assessed.%5CnRESULTS%3A%20Overall%2C%2028.2%25%20of%20survivors%20%2895%25%20confidence%20interval%20%5BCI%5D%2C%2025.6%25-30.8%25%29%20exhibited%20concentric%20remodeling%2C%202.4%25%20%2895%25%20CI%2C%201.6%25-3.5%25%29%20exhibited%20eccentric%20hypertrophy%2C%20and%201.1%25%20%2895%25%20CI%2C%200.6%25-1.9%25%29%20exhibited%20concentric%20hypertrophy.%20A%20greater%20proportion%20of%20survivors%20who%20received%20only%20chest%20radiotherapy%20%2841%25%29%20had%20concentric%20remodeling%20compared%20with%20those%20who%20received%20only%20anthracyclines%20%2824%25%29%2C%20both%20%2827%25%29%2C%20or%20neither%20%2827%25%3B%20all%20P%20%26lt%3B%20.001%29%2C%20and%20all%20were%20greater%20than%20the%20proportions%20in%20noncancer%20controls%20%2818%25%3B%20all%20P%20%26lt%3B%20.05%29.%20Concentric%20remodeling%20was%20associated%20with%20radiation%20exposure%2C%20but%20not%20with%20anthracycline%20exposure%2C%20in%20multivariable%20models.%20Survivors%20who%20had%20concentric%20remodeling%20were%20more%20likely%20to%20have%20a%20maximal%20oxygen%20uptake%20peak%20%26lt%3B85%25%20compared%20with%20those%20who%20had%20normal%20geometry%20%2881.0%25%20vs%2066.3%25%3B%20odds%20ratio%2C%201.75%3B%2095%25%20CI%2C%201.15-2.68%29.%5CnCONCLUSIONS%3A%20Chest%20radiation%20therapy%2C%20but%20not%20anthracycline%20therapy%2C%20increased%20the%20risk%20for%20concentric%20remodeling%20in%20survivors%20of%20childhood%20cancer.%20The%20presence%20of%20concentric%20remodeling%20was%20associated%20with%20increased%20exercise%20intolerance.%22%2C%22date%22%3A%22Dec%2015%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcncr.33860%22%2C%22ISSN%22%3A%221097-0142%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%2C%22AUPQENLZ%22%5D%2C%22dateModified%22%3A%222022-01-07T19%3A35%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22GC8EQIMB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Harries%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHarries%2C%20I.%2C%20Berlot%2C%20B.%2C%20Ffrench-Constant%2C%20N.%20et%20al.%20%282021%29.%20Cardiovascular%20magnetic%20resonance%20characterisation%20of%20anthracycline%20cardiotoxicity%20in%20adults%20with%20normal%20left%20ventricular%20ejection%20fraction.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B343%26lt%3B%5C%2Fi%26gt%3B%2C%20180%26%23x2013%3B186.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2021.08.037%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2021.08.037%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiovascular%20magnetic%20resonance%20characterisation%20of%20anthracycline%20cardiotoxicity%20in%20adults%20with%20normal%20left%20ventricular%20ejection%20fraction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iwan%22%2C%22lastName%22%3A%22Harries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bostjan%22%2C%22lastName%22%3A%22Berlot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natasha%22%2C%22lastName%22%3A%22Ffrench-Constant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estefania%22%2C%22lastName%22%3A%22De%20Garate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Baritussio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Biglino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Bucciarelli-Ducci%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Anthracycline%20therapy%20may%20lead%20to%20changes%20in%20cardiac%20structure%20and%20function%20not%20detectable%20by%20solely%20evaluating%20left%20ventricular%20ejection%20fraction%20%28LVEF%29.%5CnOBJECTIVES%3A%20We%20hypothesized%20that%20cardiovascular%20magnetic%20resonance%20%28CMR%29%20would%20identify%20structural%20and%20functional%20myocardial%20abnormalities%20in%20anthracycline-treated%20cancer%20survivors%20with%20normal%20LVEF%2C%20compared%20to%20a%20matched%20control%20population.%5CnMETHODS%3A%20Forty-five%20cancer%20survivors%20%2856%5Cu00a0%5Cu00b1%5Cu00a016%5Cu00a0yrs.%2C%2060%25%20female%29%20with%20normal%20LVEF%20%2859.5%5Cu00a0%5Cu00b1%5Cu00a04.1%25%29%20were%20studied%20a%20median%20of%2011%5Cu00a0months%20%28range%203-36%29%20following%20administration%20of%20237%5Cu00a0%5Cu00b1%5Cu00a083%5Cu00a0mg%5C%2Fm2%20anthracycline%2C%20and%20compared%20with%20forty-five%20healthy%20control%20subjects%20of%20similar%20age%20and%20sex%20%2853%5Cu00a0%5Cu00b1%5Cu00a016%5Cu00a0yrs.%2C%2060%25%20female%29%20with%20normal%20LVEF%20%2860.8%5Cu00a0%5Cu00b1%5Cu00a02.4%25%29%20using%201.5%5Cu00a0T%20CMR.%5CnRESULTS%3A%20Significantly%20smaller%20indexed%20left%20ventricular%20mass%20%2845.6%5Cu00a0%5Cu00b1%5Cu00a08.7%20vs%2050.3%5Cu00a0%5Cu00b1%5Cu00a010.1%5Cu00a0g%5C%2Fm2%2C%20p%5Cu00a0%3D%5Cu00a00.02%29%20and%20indexed%20myocardial%20cell%20volume%20%2830.5%5Cu00a0%5Cu00b1%5Cu00a05.7%20vs%2034.8%5Cu00a0%5Cu00b1%5Cu00a07.2%5Cu00a0ml%5C%2Fm2%2C%20p%5Cu00a0%3D%5Cu00a00.002%29%20were%20evident%20in%20cancer%20survivors%20and%20the%20latter%20was%20inversely%20associated%20with%20cumulative%20anthracycline%20dose%20%28r%5Cu00a0%3D%5Cu00a0-0.31%2C%20p%5Cu00a0%3D%5Cu00a00.02%29.%20Surrogate%20CMR%20markers%20of%20myocardial%20fibrosis%20were%20significantly%20increased%20in%20cancer%20survivors%20%28native%20myocardial%20T1%3A%201021%5Cu00a0%5Cu00b1%5Cu00a040%20vs%20996%5Cu00a0%5Cu00b1%5Cu00a035%5Cu00a0ms%2C%20p%5Cu00a0%3D%5Cu00a00.002%3B%20extracellular%20volume%3A%2029.5%5Cu00a0%5Cu00b1%5Cu00a04.5%20vs%2027.4%5Cu00a0%5Cu00b1%5Cu00a02.3%25%2C%20p%5Cu00a0%3D%5Cu00a00.006%29.%20CMR-derived%20feature-tracking%20global%20longitudinal%20strain%20%28GLS%29%20was%20significantly%20impaired%20in%20cancer%20survivors%20%282D%20GLS%20-18.3%5Cu00a0%5Cu00b1%5Cu00a02.6%20vs%20-20.0%5Cu00a0%5Cu00b1%5Cu00a02.0%25%2C%20p%5Cu00a0%26lt%3B%5Cu00a00.001%3B%203D%20GLS%20-14.5%5Cu00a0%5Cu00b1%5Cu00a02.3%20vs%20-16.4%5Cu00a0%5Cu00b1%5Cu00a02.6%25%2C%20p%5Cu00a0%26lt%3B%5Cu00a00.001%29.%20Parameters%20exhibited%20good%20to%20excellent%20%28ICC%5Cu00a0%3D%5Cu00a00.86-0.98%29%20inter-%20and%20intra-observer%20reproducibility.%5CnCONCLUSIONS%3A%20Anthracycline-treated%20cancer%20survivors%20with%20normal%20LVEF%20have%20significant%20perturbations%20of%20LV%20mass%2C%20myocardial%20cell%20volume%2C%20native%20myocardial%20T1%2C%20ECV%2C%20CMR-derived%202D%20and%203D%20GLS%2C%20compared%20to%20controls%2C%20with%20good%20to%20excellent%20levels%20of%20inter-%20and%20intra-observer%20reproducibility.%22%2C%22date%22%3A%22Nov%2015%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2021.08.037%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%5D%2C%22dateModified%22%3A%222021-10-29T18%3A45%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22I9VGHDXA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Plana%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPlana%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20C.%20%282021%29.%20A%20thriving%20new%20field.%20%26lt%3Bi%26gt%3BArq%20Bras%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B117%26lt%3B%5C%2Fi%26gt%3B%2C%20614.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.36660%5C%2Fabc.20210764%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.36660%5C%2Fabc.20210764%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20thriving%20new%20field%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%202021%22%2C%22language%22%3A%22eng%2C%20por%22%2C%22DOI%22%3A%2210.36660%5C%2Fabc.20210764%22%2C%22ISSN%22%3A%221678-4170%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22EFZ9YY7A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Koneru%2C%20S.%2C%20Krajcer%2C%20Z.%20et%20al.%20%282021%29.%20Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience.%20%26lt%3Bi%26gt%3BAnn%20Cardiothorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20630%26%23x2013%3B640.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Yazan%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20L.%22%2C%22lastName%22%3A%22McCormack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Briana%20T.%22%2C%22lastName%22%3A%22Costello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%20Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20G.%22%2C%22lastName%22%3A%22D%5Cu00edez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sept%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.21037%5C%2Facs-2021-tviv-131%22%2C%22ISSN%22%3A%222225319X%2C%2023041021%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.annalscts.com%5C%2Farticle%5C%2Fview%5C%2F16858%5C%2Fhtml%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YL3LPZGE%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22QSVIJDTT%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A43%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22XF68PEL9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nazir%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNazir%2C%20S.%2C%20Minhas%2C%20A.%20M.%20K.%2C%20Kamat%2C%20I.%20S.%20et%20al.%20%282021%29.%20Patient%20characteristics%20and%20outcomes%20of%20Type%202%20myocardial%20infarction%20during%20heart%20failure%20hospitalizations%20in%20the%20United%20States.%20%26lt%3Bi%26gt%3BAm%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%2C%20S0002-9343%2821%2900398%26%23x2013%3B3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjmed.2021.05.022%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjmed.2021.05.022%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Patient%20characteristics%20and%20outcomes%20of%20Type%202%20myocardial%20infarction%20during%20heart%20failure%20hospitalizations%20in%20the%20United%20States%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salik%22%2C%22lastName%22%3A%22Nazir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Mannan%20Khan%22%2C%22lastName%22%3A%22Minhas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ishan%20S.%22%2C%22lastName%22%3A%22Kamat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20W.%22%2C%22lastName%22%3A%22Ariss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Moukarbel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Savitri%22%2C%22lastName%22%3A%22Fedson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biykem%22%2C%22lastName%22%3A%22Bozkurt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Type%202%20myocardial%20infarction%20%28MI%29%20is%20increasingly%20diagnosed%20in%20patients%20with%20heart%20failure%20%28HF%29.%20A%20paucity%20of%20data%20exists%20pertinent%20to%20the%20contemporary%20prevalence%20and%20impact%20of%20type%202%20MI%20in%20patients%20with%20HF.%20We%20studied%20the%20patient%20profiles%20and%20the%20prognostic%20impact%20of%20type%202%20MI%20on%20outcomes%20of%20HF%20hospitalizations.%5CnMETHODS%3A%20The%20Nationwide%20Readmission%20Database%202018%20was%20queried%20for%20patients%20with%20HF%20hospitalizations%20with%20and%20without%20type%202%20MI.%20Baseline%20characteristics%2C%20inpatient%20outcomes%2C%20and%2030-day%20all-cause%20readmissions%20between%20both%20cohorts%20were%20compared.%5CnRESULTS%3A%20Of%201%2C072%2C674%20primary%20HF%20hospitalizations%20included%20in%20the%20study%2C%2028%2C813%20%282.7%25%29%20had%20type%202%20MI.%20Patients%20with%20type%202%20MI%20were%20more%20likely%20to%20be%20males%20%2856.5%25%20vs%2051.6%25%3B%20P%20%26lt%3B%20.001%29%20and%20had%20a%20higher%20prevalence%20of%20hypertension%20%2894%25%20vs%2092.2%25%3B%20P%20%26lt%3B%20.001%29%2C%20prior%20myocardial%20infarction%20%2817.1%25%20vs%2014.9%25%3B%20P%20%26lt%3B%20.001%29%2C%20anemia%20%289.1%25%20vs%208.1%25%3B%20P%20%26lt%3B%20.001%29%2C%20chronic%20kidney%20disease%20%2855.7%25%20vs%2049.4%25%3B%20P%20%26lt%3B%20.001%29%2C%20neurological%20disorders%20%289.4%25%20vs%207.3%25%3B%20P%20%26lt%3B%20.001%29%2C%20and%20weight%20loss%20%287.3%25%20vs%205.6%25%3B%20P%20%26lt%3B%20.001%29.%20Compared%20with%20their%20counterparts%20without%20type%202%20MI%2C%20patients%20with%20HF%20with%20type%202%20MI%20had%20significantly%20higher%20in-hospital%20mortality%20%28adjusted%20odds%20ratio%20%5BaOR%5D%2C%201.53%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%201.37-1.72%29%2C%20hospital%20costs%20%28adjusted%20parameter%20estimate%2C%20%241785%3B%2095%25%20CI%2C%201388-2182%29%2C%20discharge%20to%20nursing%20facility%20%28aOR%2C%201.22%3B%2095%25%20CI%2C%201.15-1.29%29%2C%20longer%20length%20of%20stay%20%28adjusted%20parameter%20estimate%2C%200.53%3B%2095%25%20CI%2C%200.42-0.64%29%2C%20and%20rate%20of%2030-day%20all-cause%20readmissions%20%28aOR%2C%201.06%3B%2095%25%20CI%2C%201.01-1.12%29.%5CnCONCLUSION%3A%20Type%202%20MI%20in%20patients%20hospitalized%20with%20HF%20is%20associated%20with%20higher%20mortality%20and%20resource%20utilization%20in%20the%20United%20States.%22%2C%22date%22%3A%22Jun%2030%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjmed.2021.05.022%22%2C%22ISSN%22%3A%221555-7162%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%2C%22S7WF6DG3%22%2C%22GL8QP2FN%22%5D%2C%22dateModified%22%3A%222023-01-12T21%3A57%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22ICCRFPZC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jneid%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJneid%2C%20H.%2C%20Suffredini%2C%20J.%20M.%20and%20%26lt%3Bstrong%26gt%3BPlana%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20C.%20%282021%29.%20Transcatheter%20therapies%20for%20severe%20aortic%20stenosis%20and%20mitral%20regurgitation%3A%20A%20tale%20of%202%20cities.%20%26lt%3Bi%26gt%3BJACC%20Cardiovasc%20Interv%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%201193%26%23x2013%3B1195.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcin.2021.03.062%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcin.2021.03.062%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20therapies%20for%20severe%20aortic%20stenosis%20and%20mitral%20regurgitation%3A%20A%20tale%20of%202%20cities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Suffredini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Jun%2014%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcin.2021.03.062%22%2C%22ISSN%22%3A%221876-7605%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%5D%2C%22dateModified%22%3A%222021-07-20T19%3A06%3A39Z%22%7D%7D%2C%7B%22key%22%3A%223SXXRRI8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Harrison%2C%20D.%2C%20Preventza%2C%20O.%20et%20al.%20%282021%29.%20Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B329%26lt%3B%5C%2Fi%26gt%3B%2C%2050%26%23x2013%3B55.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%20Y.%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20A.%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Palaskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20F.%22%2C%22lastName%22%3A%22Stainback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Chest%20radiation%20therapy%20%28CRT%29%20for%20malignant%20thoracic%20neoplasms%20is%20associated%20with%20development%20of%20valvular%20heart%20disease%20years%20later.%20As%20previous%20radiation%20exposure%20can%20complicate%20surgical%20treatment%2C%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20has%20emerged%20as%20an%20alternative.%20However%2C%20outcomes%20data%20are%20lacking%20for%20TAVR%20patients%20with%20a%20history%20of%20CRT.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20study%20of%20all%20patients%20who%20underwent%20a%20TAVR%20procedure%20at%20a%20single%20institution%20between%20September%202012%20and%20November%202018.%20Among%201341%20total%20patients%2C%2050%20had%20previous%20CRT.%20These%20were%20propensity-matched%20in%20a%201%3A2%20ratio%20to%20100%20patients%20without%20history%20of%20CRT.%20Thirty-day%20adverse%20events%20were%20analyzed%20with%20generalized%20estimating%20equation%20models.%20Overall%20mortality%20was%20analyzed%20with%20stratified%20Cox%20regression%20modelling.%5CnRESULTS%3A%20Median%20clinical%20follow-up%20was%2024%5Cu00a0months%20%28interquartile%20range%20%5BIQR%5D%2C%2012-44%5Cu00a0months%29.%20There%20was%20no%20difference%20between%20CRT%20and%20non-CRT%20patients%20in%20overall%20mortality%20%28hazard%20ratio%20%5BHR%5D%200.84%20%5B0.37-1.90%5D%2C%20P%5Cu00a0%3D%5Cu00a00.67%29%2C%2030-day%20mortality%20%28HR%203.1%20%5B0.49-20.03%5D%2C%20P%5Cu00a0%3D%5Cu00a00.23%29%2C%20or%2030-day%20readmission%20rate%20%28HR%201.0%20%5B0.43-2.31%5D%2C%20P%5Cu00a0%3D%5Cu00a01%29.%20There%20were%20no%20differences%20in%20the%20rates%20of%20most%20adverse%20events%2C%20but%20patients%20with%20CRT%20history%20had%20higher%20rates%20of%20postprocedural%20respiratory%20failure%20%28HR%203.63%20%5B1.32-10.02%5D%2C%20P%5Cu00a0%3D%5Cu00a00.01%29%20and%20permanent%20pacemaker%20implantation%20%28HR%202.84%20%5B1.15-7.01%5D%2C%20P%5Cu00a0%3D%5Cu00a00.02%29.%5CnCONCLUSIONS%3A%20For%20patients%20with%20aortic%20valve%20stenosis%20and%20previous%20CRT%2C%20TAVR%20is%20safe%20and%20effective%2C%20with%20outcomes%20similar%20to%20those%20in%20the%20general%20aortic%20stenosis%20population.%20Patients%20with%20history%20of%20CRT%20are%20more%20likely%20to%20have%20postprocedural%20respiratory%20failure%20and%20to%20require%20permanent%20pacemaker%20implantation.%22%2C%22date%22%3A%22Apr%2015%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2020.12.054%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YRK99JHR%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22AAQ89W3S%22%2C%22X6Y3USZ6%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A27%3A39Z%22%7D%7D%2C%7B%22key%22%3A%224B7Q6I5D%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nazir%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNazir%2C%20S.%2C%20Hahn%2C%20J.%2C%20Minhas%2C%20A.%20M.%20et%20al.%20%282021%29.%20Association%20of%20Type%202%20myocardial%20infarction%20with%20outcomes%20and%20resource%20utilization%20in%20patients%20undergoing%20endovascular%20transcatheter%20aortic%20valve%20replacement.%20%26lt%3Bi%26gt%3BCardiovasc%20Revasc%20Med%26lt%3B%5C%2Fi%26gt%3B%2C%20S1553-8389%2821%2900140%26%23x2013%3B8.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carrev.2021.03.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carrev.2021.03.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20Type%202%20myocardial%20infarction%20with%20outcomes%20and%20resource%20utilization%20in%20patients%20undergoing%20endovascular%20transcatheter%20aortic%20valve%20replacement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salik%22%2C%22lastName%22%3A%22Nazir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Mannan%22%2C%22lastName%22%3A%22Minhas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keerat%20Rai%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Moukarbel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%2010%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.carrev.2021.03.006%22%2C%22ISSN%22%3A%221878-0938%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%2C%222K4N54U2%22%5D%2C%22dateModified%22%3A%222021-10-29T17%3A45%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22PKXXPHFT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dixon%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDixon%2C%20S.%20B.%2C%20Howell%2C%20C.%20R.%2C%20Lu%2C%20L.%20et%20al.%20%282021%29.%20Cardiac%20biomarkers%20and%20association%20with%20subsequent%20cardiomyopathy%20and%20mortality%20among%20adult%20survivors%20of%20childhood%20cancer%3A%20A%20report%20from%20the%20St.%20Jude%20Lifetime%20Cohort.%20%26lt%3Bi%26gt%3BCancer%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B127%26lt%3B%5C%2Fi%26gt%3B%2C%20458%26%23x2013%3B466.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcncr.33292%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcncr.33292%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20biomarkers%20and%20association%20with%20subsequent%20cardiomyopathy%20and%20mortality%20among%20adult%20survivors%20of%20childhood%20cancer%3A%20A%20report%20from%20the%20St.%20Jude%20Lifetime%20Cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20B.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20R.%22%2C%22lastName%22%3A%22Howell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lu%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20C.%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijaya%20M.%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20V.%22%2C%22lastName%22%3A%22Luepker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20B.%22%2C%22lastName%22%3A%22Durand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%22%2C%22lastName%22%3A%22Ky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Lenihan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20L.%22%2C%22lastName%22%3A%22Jefferies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20M.%22%2C%22lastName%22%3A%22Green%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Ehrhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Mulrooney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20E.%22%2C%22lastName%22%3A%22Folse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20E.%22%2C%22lastName%22%3A%22Partin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%20K.%22%2C%22lastName%22%3A%22Santucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20M.%22%2C%22lastName%22%3A%22Howell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deo%20Kumar%22%2C%22lastName%22%3A%22Srivastava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20M.%22%2C%22lastName%22%3A%22Hudson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20L.%22%2C%22lastName%22%3A%22Robison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirsten%20K.%22%2C%22lastName%22%3A%22Ness%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20T.%22%2C%22lastName%22%3A%22Armstrong%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Survivors%20of%20childhood%20cancer%20exposed%20to%20cardiotoxic%20therapies%20are%20at%20significant%20cardiovascular%20risk.%20The%20utility%20of%20cardiac%20biomarkers%20for%20identifying%20the%20risk%20of%20future%20cardiomyopathy%20and%20mortality%20is%20unknown.%5CnMETHODS%3A%20N-terminal%20pro-B-type%20natriuretic%20peptide%20%28NT-proBNP%29%20and%20cardiac%20troponin%20T%20%28cTnT%29%20were%20assessed%20in%201213%20adults%2010%20or%20more%20years%20from%20a%20childhood%20cancer%20diagnosis%3B%20786%20were%20exposed%20to%20anthracycline%20chemotherapy%20and%5C%2For%20chest-directed%20radiation%20therapy%20%28RT%29.%20NT-proBNP%20values%20above%20age-%20and%20sex-specific%2097.5th%20percentiles%20were%20considered%20abnormal.%20Generalized%20linear%20models%20estimated%20cross-sectional%20associations%20between%20abnormal%20NT-proBNP%20and%20anthracycline%20or%20chest%20RT%20doses%20as%20risk%20ratios%20with%2095%25%20confidence%20intervals%20%28CIs%29.%20A%20Poisson%20distribution%20estimated%20rates%20and%20a%20Cox%20proportional%20hazards%20model%20estimated%20hazard%20ratios%20%28HRs%29%20for%20future%20cardiac%20events%20and%20death.%5CnRESULTS%3A%20At%20a%20median%20age%20of%2035.5%20years%20%28interquartile%20range%2C%2029.8-42.5%20years%29%2C%20NT-proBNP%20and%20cTnT%20were%20abnormal%20in%2022.5%25%20and%200.4%25%2C%20respectively.%20Exposure%20to%20chest%20RT%20and%20exposure%20to%20anthracycline%20chemotherapy%20were%20each%20associated%20with%20a%20dose-dependent%20increased%20risk%20for%20abnormal%20NT-proBNP%20%28P%20for%20trend%20%26lt%3B.0001%29.%20Among%20exposed%20survivors%20with%20no%20history%20of%20Common%20Terminology%20Criteria%20for%20Adverse%20Events-graded%20cardiomyopathy%20and%20with%20normal%20systolic%20function%2C%20survivors%20with%20abnormal%20NT-proBNP%20had%20higher%20rates%20per%201000%20person-years%20of%20cardiac%20mortality%20%282.93%20vs%200.96%3B%20P%20%26lt%3B%20.0001%29%20and%20future%20cardiomyopathy%20%2832.10%20vs%2015.98%3B%20P%20%26lt%3B%20.0001%29%20and%20an%20increased%20risk%20of%20future%20cardiomyopathy%20%28HR%2C%202.28%3B%2095%25%20CI%2C%201.28-4.08%29%20according%20to%20a%20multivariable%20assessment.%5CnCONCLUSIONS%3A%20Abnormal%20NT-proBNP%20values%20were%20prevalent%20and%2C%20among%20survivors%20who%20were%20exposed%20to%20cardiotoxic%20therapy%20but%20did%20not%20have%20a%20history%20of%20cardiomyopathy%20or%20current%20systolic%20dysfunction%2C%20identified%20those%20at%20increased%20risk%20for%20future%20cardiomyopathy.%20Further%20longitudinal%20studies%20are%20needed%20to%20confirm%20this%20novel%20finding.%22%2C%22date%22%3A%22Feb%201%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcncr.33292%22%2C%22ISSN%22%3A%221097-0142%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%5D%2C%22dateModified%22%3A%222021-02-11T16%3A34%3A31Z%22%7D%7D%5D%7D
Kamat, I. S., Nazir, S., Minhas, A. M. K. et al. (2022). Outcomes of hospitalizations with septic shock complicated by types 1 and 2 myocardial infarction. Am J Cardiol, S0002-9149(22)00333–2. https://doi.org/10.1016/j.amjcard.2022.03.027.
Jefferies, J. L., Mazur, W. M., Howell, C. R. et al. (2021). Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Cancer 127, 4646–4655. https://doi.org/10.1002/cncr.33860.
Harries, I., Berlot, B., Ffrench-Constant, N. et al. (2021). Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction. Int J Cardiol 343, 180–186. https://doi.org/10.1016/j.ijcard.2021.08.037.
Plana, J. C. (2021). A thriving new field. Arq Bras Cardiol 117, 614. https://doi.org/10.36660/abc.20210764.
Kherallah, R. Y., Koneru, S., Krajcer, Z. et al. (2021). Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience. Ann Cardiothorac Surg 10, 630–640. https://doi.org/10.21037/acs-2021-tviv-131.
Nazir, S., Minhas, A. M. K., Kamat, I. S. et al. (2021). Patient characteristics and outcomes of Type 2 myocardial infarction during heart failure hospitalizations in the United States. Am J Med, S0002-9343(21)00398–3. https://doi.org/10.1016/j.amjmed.2021.05.022.
Jneid, H., Suffredini, J. M. and Plana, J. C. (2021). Transcatheter therapies for severe aortic stenosis and mitral regurgitation: A tale of 2 cities. JACC Cardiovasc Interv 14, 1193–1195. https://doi.org/10.1016/j.jcin.2021.03.062.
Kherallah, R. Y., Harrison, D., Preventza, O. et al. (2021). Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329, 50–55. https://doi.org/10.1016/j.ijcard.2020.12.054.
Nazir, S., Hahn, J., Minhas, A. M. et al. (2021). Association of Type 2 myocardial infarction with outcomes and resource utilization in patients undergoing endovascular transcatheter aortic valve replacement. Cardiovasc Revasc Med, S1553-8389(21)00140–8. https://doi.org/10.1016/j.carrev.2021.03.006.
Dixon, S. B., Howell, C. R., Lu, L. et al. (2021). Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort. Cancer 127, 458–466. https://doi.org/10.1002/cncr.33292.